The FDA and CDC are investigating reports of serious adverse events, including deaths, in recipients of Ixchiq.

The Trump administration has launched a $500 million project to develop a universal flu vaccine that won't need yearly ...

UW Health's Dr. Jeff Pothof discusses FDA-approved food dyes, a new tool to test for HPV at home and the shingles vaccine.

Adults over the age of 60 are recommended not to get the chikungunya vaccine to prevent the mosquito-borne illness due to two ...

A half-decade since the pandemic, countless individuals and families have been left wondering: what is the long-term safety ...

China has reported eight more H9N2 avian flu infections in people from four different areas, along with another H10N3 avian flu case in a resident of Guangxi province, the Hong Kong Centre for Health ...

The Sioux Lookout First Nations Health Authority (SLFNHA) is reminding people of the importance of vaccination after Thunder ...

The National Institute of Allergy and Infectious Diseases (NIAID) plans to initiate phase 1 clinical trial of Capricor's ...

SOUTH SAN FRANCISCO, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) (the "Company" or "Vaxart") today announced its business update and financial results for the first quarter of ...

New recommendations from the National Academies of Sciences, Engineering, and Medicine are asking scientists to dive into ...

The United States is advising travellers aged 60 and up to hold off on getting the chikungunya vaccine while it looks into ...

The FDA and CDC recommended a pause for Ixchiq, a chikungunya vaccine, following reports of adverse events in recipients 60 ...